Biden administration unveils first 10 drugs subject to Medicare price negotiations
http://youtu.be/KopgfXdLhY0
The Biden administration on Tuesday (August 29) released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
U.S President Joe Biden said in a statement that once implemented, the prices of negotiated drugs will decrease for up to 9 million seniors who currently pay as much as $6,497 in out-of-pocket costs per year for these prescriptions.
Medicines on the list include Merck & Co's diabetes drug Januvia, Eliquis rival Xarelto from Johnson & Johnson, and AbbVie's leukemia treatment Imbruvica.
Other drugs on the list include Amgen's rheumatoid arthritis dru...




























